CC
CELG

Callan Capital’s Celgene Corp CELG Stock Holding History

Callan Capital’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-3,100
Closed -$306K – 71
2016
Q2 		$306K Hold
3,100
– – 0.12% 50
2016
Q1 		$310K Buy
3,100
+1,000
+48% +$103K 0.13% 47
2015
Q4 		$251K Hold
2,100
– – 0.1% 54
2015
Q3 		$227K Buy
+2,100
New +$261K 0.12% 56

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Callan Capital's CELG Position: Q3 2016 in Review

Callan Capital sold out of Celgene Corp (CELG) in Q3 2016, closing a stake of 3,100 shares — an estimated $306K sold.

Callan Capital first reported a position in CELG in Q3 2015 and held it in 4 quarters. The position peaked at $310K in Q1 2016. 1,277 funds tracked by Wall St. Rank hold CELG as of Q3 2016.

  • Callan Capital reported no remaining Celgene Corp position as of Q3 2016 after selling out during the quarter.
  • Callan Capital sold 3,100 Celgene Corp shares in Q3 2016, an estimated $306K.
  • Callan Capital first reported a position in Celgene Corp in Q3 2015 and held it in 4 quarters.
  • Callan Capital's Celgene Corp position peaked at $310K in Q1 2016.
  • 1,277 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2016.

Based on Callan Capital's 13F filing for Q3 2016, filed 15 Nov 2016.